Syndax Pharmaceuticals (SNDX) Tops Q2 EPS by 13c, Beats on Revenues; Offers FY17 OpEx Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. GOOGL
9. RTX
10. S

Go back to Syndax Pharmaceuticals (SNDX) Tops Q2 EPS by 13c, Beats on Revenues; Offers FY17 OpEx Guidance

Syndax Pharmaceuticals (SNDX) PT Lowered to $20 at Citi; Reiterates Buy

August 11, 2017 8:56 AM EDT

Citi lowered its price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $20.00 (from $24.00) while maintaining a Buy rating. Citi... More

Syndax Pharmaceuticals (SNDX) PT Lowered to $22 at Nomura/Instinet on Mixed 2Q Results

August 11, 2017 8:54 AM EDT

Nomura/Instinet lowered its price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $22.00 (from $27.00) while maintaining a Buy rating, following the company's second quarter earnings report.

Analyst Christopher Marai notes the company delivered second quarter earnings per share below expectations, despite revenues in-line with estimates,... More